Amgen Inc., a leading biotechnology company, was recently affected by a data breach involving its service provider, Sirva Relocation, LLC, and its parent company, Sirva, Inc. This breach potentially exposed sensitive personal information of individuals associated with Amgen.
The breach occurred between August 16, 2023, and October 17, 2023, when unauthorized actors accessed certain Sirva systems and copied files during this period. On September 29, 2023, Sirva detected suspicious activity and began an investigation, which revealed the extent of the breach. Amgen was notified on August 8, 2024, that some of the data related to its personnel might have been affected.
The breach exposed a wide range of personal data, including:
The severity of this breach is significant due to the nature and breadth of the information exposed, which could lead to identity theft or financial fraud if misused. You can find more details about the breach in the disclosure on the Massachusetts Attorney General's website and the California Attorney General's website.
Upon learning of the incident, Amgen took immediate action to understand the scope and impact of the breach. The company worked closely with Sirva to investigate the incident and assess the security of the affected systems. Amgen has also collaborated with Sirva to enhance security measures to prevent such incidents in the future. Furthermore, Amgen has notified relevant law enforcement and regulatory bodies, ensuring compliance with legal requirements.
To support those potentially affected, Amgen has engaged Kroll, a global leader in risk mitigation, to provide identity monitoring services at no cost. These services include credit monitoring, identity theft restoration, and fraud consultation, among others.
If you believe your information may have been compromised in this breach, it is crucial to remain vigilant. Here are some steps you can take:
For further assistance, you can contact Kroll at (866) 997-0255 or reach out to Amgen's Human Resources for more information.